Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Autism spectrum disorder (ASD) is characterized by deficits in sociability and communication, and increased repetitive and/or restrictive behaviors. While the etio-pathogenesis of ASD is unknown, clinical manifestations are diverse and many possible genetic and environmental factors have been implicated. As such, it has been a great challenge to identify key neurobiological mechanisms and to develop effective treatments. Current therapies focus on co-morbid conditions (such as epileptic seizures and sleep disturbances) and there is no cure for the core symptoms. Recent studies have increasingly implicated mitochondrial dysfunction in ASD. The fact that mitochondria are an integral part of diverse cellular functions and are susceptible to many insults could explain how a wide range of factors can contribute to a consistent behavioral phenotype in ASD. Meanwhile, the high-fat, low-carbohydrate ketogenic diet (KD), used for nearly a century to treat medically intractable epilepsy, has been shown to enhance mitochondrial function through a multiplicity of mechanisms and affect additional molecular targets that may address symptoms and comorbidities of ASD. Here, we review the evidence for the use of metabolism-based therapies such as the KD in the treatment of ASD as well as emerging co-morbid models of epilepsy and autism. Future research directions aimed at validating such therapeutic approaches and identifying additional and novel mechanistic targets are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., Kurzius-Spencer, M., Zahorodny, W., Robinson, C., Rosenberg, et al. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6706a1 · Cited by 6,078
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990 · cited 1×
“In most cases, Rett syndrome is caused by mutations in the methyl-CpGbinding protein 2 (MECP2) gene (Amir et al., 1999).”
BackgroundMaenner, M. J., Shaw, K. A., Baio, J., EdS1, Washington, A., Patrick, M., DiRienzo, M., Christensen, D. L., Wiggins, L. D., Pettygrove, S., et al. (2020) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6904a1 · Cited by 3,780
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781 · cited 1×
“…metabolism, intracellular calcium signaling, generation of reactive oxygen species (ROS), and apoptosis (Suen et al., 2008; Murphy, 2009; Palmieri et al., 2010; Antico Arciuch et al., 2012; Rizzuto et al., 2012), as well as in the regulation of innate and adaptive immunity (Weinberg et al., 2015).”
BackgroundSynaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747
Carnitine—metabolism and functions
Bremer, J. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.4.1420 · Cited by 1,666 · cited 1×
“It has been well established that carnitines are involved in mitochondrial transport of long-chain fatty acids and play an important role in maintaining normal mitochondrial function (Bremer, 1983).”
BackgroundGut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses
Li, Z., Okamoto, K.-I., Hayashi, Y., & Sheng, M. (2004) · Cell · doi:10.1016/j.cell.2004.11.003 · Cited by 1,498 · cited 2×
“In addition, mitochondria are involved in the proliferation, differentiation and maturation of neural stem cells, formation of dendritic processes, developmental and synaptic plasticity, and cell survival and death (Li et al., 2004; Kann and Kovacs, 2007; Mattson et al., 2008; Kimura and Murakami, 2014; Xavier et al.,…”
BackgroundAutism genome-wide copy number variation reveals ubiquitin and neuronal genes
Glessner, J. T., Wang, K., Cai, G., Korvatska, O., Kim, C. E., Wood, S., Zhang, H., Estes, A., Brune, C. W., Bradfield, J. P., et al. (2009) · Nature · doi:10.1038/nature07953 · Cited by 1,421 · cited 1×
“Glessner et al., 2009 859 Copy number variations in genes involved in the ubiquitin degradation were implicated in susceptibility for ASD.”
BackgroundPrenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Christensen, J., Grønborg, T. K., Sørensen, M. J., Schendel, D., Parner, E. T., Pedersen, L. H., & Vestergaard, M. (2013) · JAMA · doi:10.1001/jama.2013.2270 · Cited by 1,357
Costs of Autism Spectrum Disorders in the United Kingdom and the United States
Buescher, A. V. S., Cidav, Z., Knapp, M., & Mandell, D. S. (2014) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.210 · Cited by 1,296
Mitochondrial dynamics and apoptosis
Suen, D.-F., Norris, K. L., & Youle, R. J. (2008) · Genes & Development · doi:10.1101/gad.1658508 · Cited by 1,270 · cited 2×
“…are also critically involved in cellular metabolism, intracellular calcium signaling, generation of reactive oxygen species (ROS), and apoptosis (Suen et al., 2008; Murphy, 2009; Palmieri et al., 2010; Antico Arciuch et al., 2012; Rizzuto et al., 2012), as well as in the regulation of innate…”
BackgroundMost genetic risk for autism resides with common variation
Gaugler, T., Klei, L., Sanders, S. J., Bodea, C. A., Goldberg, A. P., Lee, A. B., Mahajan, M., Manaa, D., Pawitan, Y., Reichert, J., et al. (2014) · Nature Genetics · doi:10.1038/ng.3039 · Cited by 1,239 · cited 1×
“Most cases of ASD have unknown genetic underpinnings (Gaugler et al., 2014), and models of unidentified etiology have been characterized with behavioral tests assessing autistic symptomatology.”
BackgroundMitochondria in neuroplasticity and neurological disorders
Mattson, M. P., Gleichmann, M., & Cheng, A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.010 · Cited by 1,081 · cited 1×
“…involved in the proliferation, differentiation and maturation of neural stem cells, formation of dendritic processes, developmental and synaptic plasticity, and cell survival and death (Li et al., 2004; Kann and Kovacs, 2007; Mattson et al., 2008; Kimura and Murakami, 2014; Xavier et al., 2016).”
BackgroundSandin, S., Lichtenstein, P., Kuja-Halkola, R., Larsson, H., Hultman, C. M., & Reichenberg, A. (2014) · JAMA · doi:10.1001/jama.2014.4144 · Cited by 1,073
Excitatory/Inhibitory Balance and Circuit Homeostasis in Autism Spectrum Disorders
Nelson, S. B., & Valakh, V. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.033 · Cited by 1,001
Pyrosequencing study of fecal microflora of autistic and control children
Finegold, S. M., Dowd, S. E., Gontcharova, V., Liu, C., Henley, K. E., Wolcott, R. D., Youn, E., Summanen, P. H., Granpeesheh, D., Dixon, D., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.06.008 · Cited by 977
From the genetic architecture to synaptic plasticity in autism spectrum disorder
Bourgeron, T. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3992 · Cited by 975 · cited 2×
“…remodeling, protein translation and modification, neuroimmunological modulation, and mitochondrial function (Veenstra-Vanderweele et al., 2004; Bourgeron, 2015; De Rubeis and Buxbaum, 2015; Kopp et al., 2015; Loke et al., 2015; Mahfouz et al., 2015; Nelson and Valakh, 2015; Subramanian et…”
BackgroundAutism From 2 to 9 Years of Age
Lord, C., Risi, S., DiLavore, P. S., Shulman, C., Thurm, A., & Pickles, A. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.694 · Cited by 973 · cited 1×
“However, on average, children are not diagnosed until after 4 years of age (CDC, 2014), even though patients can now be reliably diagnosed at 2 years of age (Lord et al., 2006; Kleinman et al., 2008).”
BackgroundMitochondria in the Regulation of Innate and Adaptive Immunity
Weinberg, S. E., Sena, L. A., & Chandel, N. S. (2015) · Immunity · doi:10.1016/j.immuni.2015.02.002 · Cited by 960
De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D. I., Cristofori, F., Guerzoni, M. E., Gobbetti, M., & Francavilla, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076993 · Cited by 887 · cited 1×
“In addition, a KD decreased total host bacterial abundance in both sample types, and in the BTBR animals counteracted a low Firmicutes to Bacteroidetes ratio, which is commonly observed in patients with ASD (Finegold et al., 2010; De Angelis et al., 2013).”
BackgroundAdvancing the understanding of autism disease mechanisms through genetics
de la Torre-Ubieta, L., Won, H., Stein, J. L., & Geschwind, D. H. (2016) · Nature Medicine · doi:10.1038/nm.4071 · Cited by 827
Autism‐like behavioral phenotypes in BTBR T+tf/J mice
McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., & Crawley, J. N. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00330.x · Cited by 812
Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strains
MOY, S., NADLER, J., YOUNG, N., PEREZ, A., HOLLOWAY, L., BARBARO, R., BARBARO, J., WILSON, L., THREADGILL, D., & LAUDER, J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.07.030 · Cited by 776
Perinatal and Neonatal Risk Factors for Autism: A Comprehensive Meta-analysis
Gardener, H., Spiegelman, D., & Buka, S. L. (2011) · Pediatrics · doi:10.1542/peds.2010-1036 · Cited by 665 · cited 1×
“…time of conception, adverse metabolic conditions and/or maternal illness during pregnancy, birth complications, and exposure to toxins and/or drugs during early brain development (Stromland et al., 1994; Durkin et al., 2008; Gardener et al., 2011; Krakowiak et al., 2012; Christensen et al., 2013).”
BackgroundDisentangling the heterogeneity of autism spectrum disorder through genetic findings
Jeste, S. S., & Geschwind, D. H. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.278 · Cited by 644 · cited 1×
“Genome screening and sequencing has identified rare chromosomal abnormalities and copy number variations, as well as hundreds of rare gene mutations associated with autism (Devlin and Scherer, 2012; Huguet et al., 2013; Jeste and Geschwind, 2014; Baker and Jeste, 2015).”
BackgroundThe Co-Morbidity Burden of Children and Young Adults with Autism Spectrum Disorders
Kohane, I. S., McMurry, A., Weber, G., MacFadden, D., Rappaport, L., Kunkel, L., Bickel, J., Wattanasin, N., Spence, S., Murphy, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033224 · Cited by 562
Genetic architecture in autism spectrum disorder
Devlin, B., & Scherer, S. W. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.03.002 · Cited by 545
Gastrointestinal Problems in Children with Autism, Developmental Delays or Typical Development
Chaidez, V., Hansen, R. L., & Hertz-Picciotto, I. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1973-x · Cited by 528
Maternal infection and immune involvement in autism
Patterson, P. H. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.001 · Cited by 520 · cited 1×
“Beyond these core behavioral symptoms, ASD is increasingly shown to affect the gastrointestinal, immune, hepatic, and endocrine systems (Goines and Van de Water, 2010; Patterson, 2011; Hsiao, 2013; Frye et al., 2015; Mayer et al., 2015).”
BackgroundLevy, S. E., Giarelli, E., Lee, L.-C., Schieve, L. A., Kirby, R. S., Cunniff, C., Nicholas, J., Reaven, J., & Rice, C. E. (2010) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3181d5d03b · Cited by 504 · cited 1×
“The co-occurrence rate of one or more non-ASD developmental diagnoses is as high as 83% (Levy et al., 2010).”
BackgroundHansen, S. N., Schendel, D. E., & Parner, E. T. (2015) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2014.1893 · Cited by 461 · cited 1×
“The prevalence appears to be on the rise (a 10-fold increase in 40 years), and is explained only in part by improved diagnosis and awareness (Hansen et al., 2015).”
BackgroundThe developmental neurobiology of autism spectrum disorder
DiCicco-Bloom, E., Lord, C., Zwaigenbaum, L., Courchesne, E., Dager, S. R., Schmitz, C., Schultz, R. T., Crawley, J., & Young, L. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1712-06.2006 · Cited by 434 · cited 1×
“The hope is that reducing co-morbidities such as epileptic seizures, psychiatric disturbances, hyperactivity, sleep problems and digestive issues (DiCicco-Bloom et al., 2006; Llaneza et al., 2010; Lai et al., 2014) will improve overall function and reduce the severity of ASD symptoms (Kohane et…”
BackgroundAutism: Many Genes, Common Pathways?
Geschwind, D. H. (2008) · Cell · doi:10.1016/j.cell.2008.10.016 · Cited by 328 · cited 1×
“Given such extreme etiological diversity, it is reasonable to hypothesize that perturbation of a common nexus can precipitate the behavioral hallmarks of ASD (Geschwind, 2008; Berg and Geschwind, 2012).”
BackgroundNaviaux, J. C., Wang, L., Li, K., Bright, A., Alaynick, W. A., Williams, K. R., Powell, S. B., & Naviaux, R. K. (2015) · Molecular Autism · doi:10.1186/2040-2392-6-1 · Cited by 285
Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms
Tordjman, S., Somogyi, E., Coulon, N., Kermarrec, S., Cohen, D., Bronsard, G., Bonnot, O., Weismann-Arcache, C., Botbol, M., Lauth, B., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00053 · Cited by 283 · cited 1×
“Genetic susceptibility factors and environmental influences (and likely often both) contribute to ASD (Chaste and Leboyer, 2012; Sandin et al., 2014; Tordjman et al., 2014; Kim and Leventhal, 2015).”
BackgroundApplication of a ketogenic diet in children with autistic behavior: Pilot study
Evangeliou, A., Vlachonikolis, I., Mihailidou, H., Spilioti, M., Skarpalezou, A., Makaronas, N., Prokopiou, A., Christodoulou, P., Liapi-Adamidou, G., Helidonis, E., et al. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180020501 · Cited by 279 · cited 1×
“…study in autistic children aged between 4 and 10 years carried out by Evangeliou and Frontiers in Molecular Neuroscience | www.frontiersin.org 5 February 2017 | Volume 10 | Article 34 colleagues; they applied an intermittent modified medium-chain triglyceride (MCT) diet (Evangeliou et al., 2003).”
MethodKetogenic diet modifies the gut microbiota in a murine model of autism spectrum disorder
Newell, C., Bomhof, M. R., Reimer, R. A., Hittel, D. S., Rho, J. M., & Shearer, J. (2016) · Molecular Autism · doi:10.1186/s13229-016-0099-3 · Cited by 272 · cited 2×
“Interestingly, a recent study showed that gut microbiota composition of cecal and fecal samples was significantly altered in BTBR mice compared to B6 animals (Newell et al., 2016).”
BackgroundResultGene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome
Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., MacLeod, N., & Bird, A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01665-05 · Cited by 219
The ketogenic diet and brain metabolism of amino acids: Relationship to the anticonvulsant effect
Yudkoff, M., Daikhin, Y., Melø, T. M., Nissim, I., Sonnewald, U., & Nissim, I. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.27.061406.093722 · Cited by 202 · cited 1×
“…in more detail in the main text. ion channels (Tigerholm et al., 2012; Lutas and Yellen, 2013) and glutamatergic synaptic transmission (Xu et al., 2006; Juge et al., 2010; Lutas and Yellen, 2013; Chang et al., 2016), as well as possible regulation of GABA production (Yudkoff et al., 2007).”
BackgroundMitochondrial abnormalities in temporal lobe of autistic brain
Tang, G., Gutierrez Rios, P., Kuo, S.-H., Akman, H. O., Rosoklija, G., Tanji, K., Dwork, A., Schon, E. A., DiMauro, S., Goldman, J., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.006 · Cited by 194 · cited 1×
“Tang et al., 2013 45 Mitochondrial function and intracellular redox status were compromised in the pyramidal neurons of the temporal cortex.”
BackgroundAutism genetics: searching for specificity and convergence
Berg, J. M., & Geschwind, D. H. (2012) · Genome Biology · doi:10.1186/gb-2012-13-7-247 · Cited by 192 · cited 1×
“Given such extreme etiological diversity, it is reasonable to hypothesize that perturbation of a common nexus can precipitate the behavioral hallmarks of ASD (Geschwind, 2008; Berg and Geschwind, 2012).”
BackgroundKetogenic Diet Improves Core Symptoms of Autism in BTBR Mice
Ruskin, D. N., Svedova, J., Cote, J. L., Sandau, U., Rho, J. M., Kawamura, M., Boison, D., & Masino, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065021 · Cited by 173 · cited 3×
“…displays all the core behavioral features that define the disorder (Moy et al., 2007; McFarlane et al., 2008; Meyza et al., 2013; Frontiers in Molecular Neuroscience | www.frontiersin.org 6 February 2017 | Volume 10 | Article 34 Ruskin et al., 2013; Smith et al., 2014; Ellegood and Crawley, 2015).”
BackgroundSelf-citationRose, S., Frye, R. E., Slattery, J., Wynne, R., Tippett, M., Pavliv, O., Melnyk, S., & James, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085436 · Cited by 168 · cited 1×
“Rose et al., 2014 25 Mitochondrial dysfunction observed in a subset of autism lymphoblastoid cell lines.”
BackgroundWen, Y., Alshikho, M. J., & Herbert, M. R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0153329 · Cited by 150
The BTBR T+tf/J mouse model for autism spectrum disorders–in search of biomarkers
Meyza, K. Z., Defensor, E. B., Jensen, A. L., Corley, M. J., Pearson, B. L., Pobbe, R. L. H., Bolivar, V. J., Blanchard, D. C., & Blanchard, R. J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.021 · Cited by 147
Rett Syndrome: Exploring the Autism Link
Percy, A. K. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.149 · Cited by 144
IMGSAC, Maestrini, E., Pagnamenta, A. T., Lamb, J. A., Bacchelli, E., Sykes, N. H., Sousa, I., Toma, C., Barnby, G., Butler, H., et al. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.34 · Cited by 143 · cited 2×
“In addition, the gene encoding an inner mitochondrial membrane protease-like protein (IMMP2L) may help regulate susceptibility to ASD (Maestrini et al., 2010).”
BackgroundNaviaux, J. C., Schuchbauer, M. A., Li, K., Wang, L., Risbrough, V. B., Powell, S. B., & Naviaux, R. K. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.33 · Cited by 134 · cited 1×
“Naviaux et al., 2013, 2014, 2015 Anti-purinergic therapy improved autism-like features in the maternal immune activation mouse model and the Fragile X mouse model.”
BackgroundInan, M., Zhao, M., Manuszak, M., Karakaya, C., Rajadhyaksha, A. M., Pickel, V. M., Schwartz, T. H., Goldstein, P. A., & Manfredi, G. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.004 · Cited by 118
Frye, R. E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.134 · Cited by 117
Genetic and functional analyses demonstrate a role for abnormal glycinergic signaling in autism
Pilorge, M., Fassier, C., Le Corronc, H., Potey, A., Bai, J., De Gois, S., Delaby, E., Assouline, B., Guinchat, V, Devillard, F., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.139 · Cited by 110 · cited 2×
“However, they are highly expressed in the embryonic brain and mediate excitatory neurotransmission, and are believed to promote cortical interneuron migration and generation of excitatory projection neurons (Pilorge et al., 2016).”
BackgroundFrye, R. E., & Rossignol, D. A. (2016) · Clinical Medicine Insights Pediatrics · doi:10.4137/cmped.s38337 · Cited by 96 · cited 1×
“…such as epileptic seizures, psychiatric disturbances, hyperactivity, sleep problems and digestive issues (DiCicco-Bloom et al., 2006; Llaneza et al., 2010; Lai et al., 2014) will improve overall function and reduce the severity of ASD symptoms (Kohane et al., 2012; Frye and Rossignol, 2016).”
BackgroundJin, L.-W., Horiuchi, M., Wulff, H., Liu, X.-B., Cortopassi, G. A., Erickson, J. D., & Maezawa, I. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2778-14.2015 · Cited by 88 · cited 1×
“Jin et al., 2015 Mecp2, whose mutations cause Rett syndrome, was observed to regulate mitochondrial bioenergetics through a glutamine transporter in microglia.”
BackgroundImmune Dysregulation in Autism Spectrum Disorder
Hsiao, E. Y. (2013) · International Review of Neurobiology · doi:10.1016/b978-0-12-418700-9.00009-5 · Cited by 87
Su, H., Fan, W., Coskun, P. E., Vesa, J., Gold, J.-A., Jiang, Y.-H., Potluri, P., Procaccio, V., Acab, A., Weiss, J. H., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.079 · Cited by 80 · cited 1×
“Su et al., 2011 Mitochondrial dysfunction observed in hippocampal neurons of the UBE3A-deficient mouse model of Angelman syndrome.”
BackgroundPark, M. J., Aja, S., Li, Q., Degano, A. L., Penati, J., Zhuo, J., Roe, C. R., & Ronnett, G. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109527 · Cited by 62 · cited 1×
“Park et al., 2014 Dietary therapy with triheptanoin enhanced mitochondrial substrate use and improved metabolism and behaviors of Mecp2-null mouse model of Rett syndrome.”
BackgroundSilverman, J. M., Buxbaum, J. D., Ramoz, N., Schmeidler, J., Reichenberg, A., Hollander, E., Angelo, G., Smith, C. J., & Kryzak, L. A. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30614 · Cited by 55
Mychasiuk, R., & Rho, J. M. (2017) · Autism Research · doi:10.1002/aur.1682 · Cited by 45 · cited 1×
“…its discovery as an ASD model, the BTBR strain has been increasingly used to study the etiology and to uncover potential interventions for ASD (Moy et al., 2007; McFarlane et al., 2008; Llaneza et al., 2010; Ruskin et al., 2013; Cheng et al., 2016; Mychasiuk and Rho, 2016; Newell et al., 2016).”
BackgroundSelf-citation
Cited by
Al-Beltagi, M. (2021) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v10.i3.15 · Cited by 273
Zhang, M., Ma, W., Zhang, J., He, Y., & Wang, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-32219-2 · Cited by 188
Wang, J., Fröhlich, H., Torres, F. B., Silva, R. L., Poschet, G., Agarwal, A., & Rappold, G. A. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112852119 · Cited by 81
Vargason, T., Frye, R. E., McGuinness, D. L., & Hahn, J. (2019) · Autism Research · doi:10.1002/aur.2128 · Cited by 59
Grayaa, S., Zerbinati, C., Messedi, M., HadjKacem, I., Chtourou, M., Ben Touhemi, D., Naifar, M., Ayadi, H., Ayedi, F., & Iuliano, L. (2018) · Biochimie · doi:10.1016/j.biochi.2018.04.026 · Cited by 56
Metadata
- Authors
- Cheng, N., Rho, J. M., & Masino, S. A.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-02-21
- Volume
- 10
- Pages
- 34-34
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2591444651
- Cited by
- 145
- References
- 60
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.